The first phase of Chinese Pharmaceutical Health Care Group factory which consumed USD 20 million and was constructed in Hageremariam, Amhara region has been completed and is now producing medicine.
The products are in four forms, tablets, capsules, injections and syrups. They are now being sold locally and to other East African countries. So far the factory which lies on seven hectares has created job opportunities for 300 Ethiopians and will triple production capacity and labor when the second and the third phase of the factory is completed. The cost of that expansion will be USD 80 million.
The new manufacturing facility is equipped with advanced technology to produce high-quality pharmaceutical products.
The facility also has a pharmaceutical packaging line equipped with labeling, carton making, shrink wrapping, packing, and blistering machines.
LU Xian, manager of the factory told Capital that the new facility strictly adheres to the WHO guidelines.
“We take great pride in formally opening our factory in Ethiopia. This business initiative forms part of Humanwell’s stated global expansion strategy into emerging and established markets, and we look forward to working closely with the Ethiopian government and local regulatory bodies in providing quality products to meet the healthcare needs of the Ethiopian people.’’
“In an effort to relieve the country’s reliance on imported pharmaceutical products the new factory will play a role in reducing imports from abroad, while meeting international standards and providing the Ethiopian people with affordable medicine.” He added the facility will offer 30 different types of medicine, ranging from simple oral products such as tablets, capsules, and powders before expanding to more sophisticated medication capable of treating diseases like hypertension, diabetes and heart disease.
Ethiopia relies heavily on India, Europe and China, for pharmaceutical products.
Humanwell was found in 1993 by a group of passionate college graduates and now since has transformed into a fully integrated healthcare solution provider. Headquartered at the center of China, Humanwell has been an active presence in over ten countries and districts to date. It has operations in China, West Africa (Mali), American markets and has registered 400 products through the national (Chinese) regulatory authority. Since its establishment, Humanwell has been striving to bring safe and effective medicines to the world through the quality of its products and the integrity of its people.